Valuation: Zai Lab Limited

Market Cap 2.53B 2.27B 2.12B 1.92B 3.61B 240B 3.63B 25.44B 9.93B 125B 9.48B 9.28B 401B P/E 2026 *
-10.2x
P/E 2027 * -10.2x
Enterprise Value 2.07B 1.86B 1.74B 1.57B 2.95B 197B 2.97B 20.83B 8.13B 102B 7.77B 7.6B 329B EV / Sales 2026 *
4.74x
EV / Sales 2027 * 3.89x
Free-Float
94.05%
Yield 2026 *
-
Yield 2027 * -
1 day-2.60%
1 week-11.10%
Current month-14.58%
1 month-8.46%
3 months+16.58%
6 months+2.46%
Current year+27.55%
1 week 22.12
Extreme 22.12
25.92
1 month 22.12
Extreme 22.12
27.14
Current year 15.96
Extreme 15.96
27.5
1 year 15.96
Extreme 15.96
30
3 years 13.48
Extreme 13.48
44.34
5 years 13.48
Extreme 13.48
105.85
10 years 13.48
Extreme 13.48
193.54
Manager TitleAgeSince
Chief Executive Officer 61 31/03/2014
Director of Finance/CFO 58 06/07/2023
President 62 30/11/2022
Director TitleAgeSince
Chairman 61 31/03/2014
Director/Board Member 83 31/12/2016
Director/Board Member 75 31/12/2016
Date Insider Type Main position Quantity % Market Cap. Importance
01/10/26 Exercice

Chief Financial Officer

2,155 0.0002%
19/08/26 Sell

Chief Financial Officer

-260 0.0000%
14/08/26 Exercice

Chief Financial Officer

2,927 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-2.60%-11.10%-23.47%-10.79% 2.53B
+3.62%+1.68%+48.80%+98.41% 1,077B
+2.13%-1.76%+33.04%+61.88% 612B
+3.32%+4.47%+23.72%+91.59% 501B
+3.80%+3.21%+73.99%+41.69% 364B
+0.74%+3.03%+29.59%+45.42% 353B
+1.42%+2.20%+17.90%+40.15% 278B
+0.87%+0.99%-3.44%+12.08% 251B
+3.21%+3.15%+45.01%+49.99% 230B
+3.80%+4.56%+29.59%+97.73% 190B
Average +1.83%+0.66%+27.47%+52.82% 385.9B
Weighted average by Cap. +2.18%+1.57%+36.82%+68.74%

Financials

2026 *2027 *
Net sales 436M 392M 366M 332M 623M 41.54B 627M 4.4B 1.72B 21.56B 1.64B 1.6B 69.33B 552M 496M 463M 420M 788M 52.54B 793M 5.56B 2.17B 27.27B 2.07B 2.03B 87.71B
Net income -241M -216M -202M -183M -344M -22.9B -346M -2.42B -946M -11.89B -904M -884M -38.23B -211M -190M -177M -161M -301M -20.09B -303M -2.13B -830M -10.43B -792M -775M -33.53B
Net Debt -458M -411M -384M -348M -653M -43.55B -657M -4.61B -1.8B -22.6B -1.72B -1.68B -72.7B -381M -342M -320M -290M -544M -36.24B -547M -3.83B -1.5B -18.81B -1.43B -1.4B -60.49B
Projected Income Statement - Annual - Zai Lab Limited
Logo Zai Lab Limited
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Employees
1,784
Date Price Change Volume
14/10/26 US$22.50 -2.60% 849,720
13/10/26 US$23.10 -6.06% 778,449
12/10/26 US$24.59 -1.60% 524,513
09/10/26 US$24.99 +0.73% 1,024,847
08/10/26 US$24.81 -1.98% 979,228
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Zai Lab Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
22.50USD
Average target price
33.14USD
Spread / Average Target
+47.29%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Zai Lab Limited
  1. Stock Market
  2. Stocks
  3. ZLAB Stock